SOPHiA GENETICS (SOPH)
(Delayed Data from NSDQ)
$3.23 USD
+0.06 (1.89%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $3.23 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, SOPHiA GENETICS SA has a market cap of $214.23M, which represents its share price of $3.17 multiplied by its outstanding shares number of 67.58M. As a small-cap company, SOPH's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SOPH 3.23 +0.06(1.89%)
Will SOPH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SOPH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SOPH
Strategic Partnerships Power Tempus AI's Healthcare Expansion
Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold?
SOPH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy?
TEM Shares Surge on New AI Breakthrough: Should Investors Jump In?
Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today?
Other News for SOPH
SOPH forms NR7 on September 15
NR7 appears for SOPH after 2.5% move
Is SOPH setting up for a drop? Fell Below 200 Day Moving Average shows up after declining 3.32%
Crossed Above 200 Day Moving Average appears for SOPH after 1.53% move
Fell Below 200 Day Moving Average appears for SOPH after 1.81% move